This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Thermo Fisher Scientific Bilan de santé
Santé financière contrôle des critères 3/6
Thermo Fisher Scientific has a total shareholder equity of $47.5B and total debt of $35.2B, which brings its debt-to-equity ratio to 74.1%. Its total assets and total liabilities are $98.5B and $51.0B respectively. Thermo Fisher Scientific's EBIT is $7.5B making its interest coverage ratio 22.6. It has cash and short-term investments of $8.8B.
Informations clés
74.1%
Ratio d'endettement
US$35.22b
Dette
Ratio de couverture des intérêts | 22.6x |
Argent liquide | US$8.82b |
Fonds propres | US$47.54b |
Total du passif | US$50.96b |
Total des actifs | US$98.50b |
Mises à jour récentes de la santé financière
Pas de mise à jour
Recent updates
Analyse de la situation financière
Passif à court terme: TN8's short term assets ($25.5B) exceed its short term liabilities ($14.8B).
Passif à long terme: TN8's short term assets ($25.5B) do not cover its long term liabilities ($36.2B).
Historique et analyse du ratio d'endettement
Niveau d'endettement: TN8's net debt to equity ratio (55.5%) is considered high.
Réduire la dette: TN8's debt to equity ratio has increased from 66.4% to 74.1% over the past 5 years.
Couverture de la dette: TN8's debt is well covered by operating cash flow (26.5%).
Couverture des intérêts: TN8's interest payments on its debt are well covered by EBIT (22.6x coverage).